Nature's Sunshine delivered a strong second quarter in 2025, with net sales increasing by 4% to $114.8 million and adjusted EBITDA rising by 8% to $11.3 million year-over-year. The company saw particular strength in Asia and North America, alongside improvements in gross profit margin and a decrease in volume incentives as a percentage of net sales.
Net sales increased by 4% to $114.8 million in Q2 2025 compared to $110.6 million in the same period last year.
GAAP net income attributable to common shareholders significantly increased to $5.3 million, or $0.28 per diluted common share, from $1.3 million, or $0.07 per diluted common share, in Q2 2024.
Adjusted EBITDA grew by 8% to $11.3 million, up from $10.4 million in the prior year quarter, primarily driven by increased net sales.
Gross profit margin improved to 71.7% in Q2 2025 from 71.4% in Q2 2024, attributed to cost savings initiatives.
Nature's Sunshine has raised its full-year 2025 net sales and adjusted EBITDA guidance, reflecting confidence in continued growth despite macroeconomic uncertainties.
Visualization of income flow from segment revenue to net income